Stanford Interstitial Lung Disease Symposium: An Image-Centered Approach to Early Diagnosis and Treatment

When:
February 10, 2018 all-day
2018-02-10T00:00:00-08:00
2018-02-11T00:00:00-08:00
Where:
San Jose Marriott
301 S Market St
San Jose, CA 95113
USA
Contact:
+1- 650-497-8554

Presented by the Division of Pulmonary and Critical Care and the Stanford University School of Medicine.

Please register early – space is limited!

This CME event led by the Stanford Division of Pulmonary and Critical Care seeks to fulfill the need of practicing pulmonologists, primary care physicians, advanced-practice providers, and allied health care practitioners in the academic and community settings to achieve an accurate diagnosis and implement a comprehensive treatment plan for patients with interstitial lung disease. A team of multidisciplinary experts will address common challenges in radiographic interpretation, diagnostic testing and classification, and disease management. The goal of the symposium is to improve the delivery of early appropriate, and comprehensive care to the patient with the interstitial lung disease.

 

TARGET AUDIENCE

This local and regional conference is designed to meet the educational needs of:

  • physicians
  • Nurses
  • Nurses practitioners
  • Health care professionals

LEARNING OBJECTIVES

At the conclusion of this activity, participants should be able to:

  • List critical findings in the history and physical exam specific to interstitial lung disease (ILD) patients
  • Describe serologic tests indicated for different populations of ILD patients with or without rheumatologic symptoms
  • Manage patients using diagnostic criteria outlined in the ATS ILD Guidelines
  • Use anti-fibrotic therapy for appropriate patients and develop comprehensive multidisciplinary management strategies
  • Utilize radiologic algorithms and classification criteria for fibrosing and nonfibrosing interstitial pneumonias
  • Determine the role of lung biopsy in the diagnosis of ILDs including patient selection, modality of biopsy, and risk/benefit analysis
  • Identify non-pharmacologic treatments to provide for ILD patients at their first clinic visit
  • Explain the criteria and timing for the referral of an ILD patient for a lung transplant evaluation
  • Describe the current status of stem cell research related to ILDs

COURSE DIRECTORS

Dr. Rishi Raj

Rishi Raj, MD

Course Director
Clinical Professor, Medicine – Pulmonary & Critical Care;
Director, Interstitial Lung Disease Program

Dr. Joshua Mooney

Joshua Mooney, MD, MS

Course Co-Director
Clinical Assistant Professor Medicine – Pulmonary & Critical Care Medicine;
Director, Stanford Pulmonary Fibrosis Foundation Care Center